Ordula 100mg Injection

Ordula 100mg Injection is an antifungal medication belonging to the class of fungal ergosterol synthesis inhibitors, containing the active ingredient Anidulafungin. It is indicated for treatment of certain invasive fungal infections. It is effective against various types of invasive candidiasis, including candidemia (Candida bloodstream infection) and oesophagal candidiasis (fungal infection of the oesophagus). Invasive candidiasis occurs when Candida yeasts enter the bloodstream or other internal organs and cause systemic infections.

Ordula 100mg Injection is contraindicated in individuals with known hypersensitivity or allergy to the drug or its components. If patients develop liver problems during treatment, their doctor may elect to monitor liver function more closely. Ordula 100mg Injection is primarily metabolised in the liver, making regular assessment of liver function important, especially in patients with pre-existing liver conditions.

Inform your physician, including an anesthesiologist, about your treatment with this drug, particularly before undergoing surgery or receiving anaesthesia. The combination of certain anaesthetics with this medication could interact, necessitating awareness of your medication history among medical professionals.

Attention should be paid to unusual symptoms such as shortness of breath, breathing difficulties, lightheadedness, or dizziness during treatment. If you experience any of these symptoms, contact your physician immediately.

Safety of Ordula 100mg Injection in pregnant women is not established, and it is not recommended during pregnancy due to limited data. If a woman of childbearing age is prescribed this drug, effective contraception should be used during the treatment period to prevent pregnancy. The effect of this drug on breastfeeding women is unknown. Breastfeeding women should contact their doctor for advice before taking this medicine.

Treatment of invasive candidiasis (fungal bloodstream infections) Management of oesophageal candidiasis (fungal infection of the oesophagus) Effective against Candida species, including fluconazole-resistant strains Used in hospitalised patients with severe fungal infections Helps in immunocompromised patients (e.g., cancer, organ transplant recipients)

Ordula 100mg Injection (Anidulafungin) is an antifungal medication used to treat invasive candidiasis and oesophageal candidiasis. It works by inhibiting fungal cell wall synthesis, leading to the destruction of Candida species, including fluconazole-resistant strains. This injection is particularly beneficial for immunocompromised patients, such as those undergoing chemotherapy or organ transplants, as it helps control severe fungal infections. By reducing symptoms like fever, chills, and organ dysfunction, Eraxis promotes faster recovery and lowers the risk of complications. Its broad-spectrum antifungal action makes it a crucial treatment option for systemic fungal infections.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Convulsion (seizure) Flushing Rash, pruritus (itching) Hot flush Hives Wheezing Coughing Difficulty of breathing Common Low blood potassium (hypokalaemia) Diarrhea Nausea Headache Vomiting

Ordula 100mg Injection is administered intravenously (directly into a vein) through an infusion. Some people may experience infusion-related reactions during or after the treatment. Inform your doctor immediately if you notice any of these symptoms during or after the infusion.